CURI (CuriosityStream Inc. Class A Common Stock) Stock Analysis - Analyst Ratings

CuriosityStream Inc. Class A Common Stock (CURI) is a publicly traded Communication Services sector company. As of May 21, 2026, CURI trades at $2.59 with a market cap of $162.74M and a P/E ratio of -20.27. CURI moved -2.99% today. Year to date, CURI is -30.67%; over the trailing twelve months it is -58.80%. Its 52-week range spans $1.47 to $7.15. Analyst consensus is strong buy with an average price target of $5.33. Rallies surfaces CURI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate CURI?

3 analysts cover CURI: 0 strong buy, 3 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $5.33.

CURI Key Metrics

Key financial metrics for CURI
MetricValue
Price$2.59
Market Cap$162.74M
P/E Ratio-20.27
EPS$-0.13
Dividend Yield0.09%
52-Week High$7.15
52-Week Low$1.47
Volume421.97K
Avg Volume0
Revenue (TTM)$71.73M
Net Income$-8.07M
Gross Margin0.00%

CURI Analyst Consensus

3 analysts cover CURI: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $5.33.

Latest CURI News

Recent CURI Insider Trades

  • Hayden Phillip Brady sold 17.47K (~$65.66K) on Jan 2, 2026.
  • Hayden Phillip Brady sold 2.00K (~$9.18K) on Dec 15, 2025.
  • Cudahy Theresa Ellen sold 5.77K (~$28.70K) on Dec 10, 2025.

Common questions about CURI

What do analysts rate CURI?
3 analysts cover CURI: 0 strong buy, 3 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $5.33.
Does Rallies show CURI price targets?
Yes. Rallies tracks CURI analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is CURI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CURI. It does not provide personalized investment advice.
CURI

CURI